Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase 1b Multicenter, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tune-401 in Participants With Chronic Hepatitis B Infection

NCT06671093 is registered in ClinicalTrials.gov with Tune Therapeutics, Inc. as lead sponsor.

NCT NCT06671093
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06671093 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase 1b Multicenter, Open-Label Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Tune-401 in Participants With Chronic Hepatitis B Infection
Lead sponsor
Tune Therapeutics, Inc.
Phase
Phase 1
Overall status
Recruiting
Start date
November 29, 2024
Completion date
October 30, 2028
Enrollment
36 (estimated)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

chronic hep b, chronic hepatitis, chronic hepatitis b, hbv